Literature DB >> 4325606

Prostaglandin E1 and noradrenaline at the neuromuscular junction.

B L Ginsborg, G D Hirst.   

Abstract

The effects of prostaglandin E(1) (PGE(1)) on neuromuscular transmission in the frog nerve-sartorius muscle preparation were studied with intracellular recording techniques. PGE(1) was inactive in all concentrations examined; both spontaneous miniature end-plate potentials and evoked end-plate potentials were unchanged after preparations were bathed in up to 2.2x10(-5)M (8 mug/ml) PGE(1). PGE(1) did not prevent the increase in end-plate potential amplitude which frequently occurred on addition of noradrenaline to the bathing solution.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4325606      PMCID: PMC1666991          DOI: 10.1111/j.1476-5381.1971.tb07095.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  An analysis of the end-plate potential recorded with an intracellular electrode.

Authors:  P FATT; B KATZ
Journal:  J Physiol       Date:  1951-11-28       Impact factor: 5.182

Review 2.  Hypotheses on physiological roles of prostaglandins.

Authors:  E W Horton
Journal:  Physiol Rev       Date:  1969-01       Impact factor: 37.312

3.  The effect of noradrenaline on the end-plate potential in twitch fibres of the frog.

Authors:  D H Jenkinson; B A Stamenović; B D Whitaker
Journal:  J Physiol       Date:  1968-04       Impact factor: 5.182

4.  Evidence for a role of cyclic AMP in neuromuscular transmission.

Authors:  A L Goldberg; J J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

5.  Prostaglandin: release from the rat phrenic nerve--diaphragm preparation.

Authors:  P W Ramwell; J E Shaw; J Kucharski
Journal:  Science       Date:  1965-09-17       Impact factor: 47.728

  5 in total
  1 in total

1.  Effect of prostaglandin E1 on neuromuscular transmission in the rat.

Authors:  J Gripenberg; S E Jansson; V Heinänen; E Heinonen; J Hyvärinen; E M Tolppanen
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.